ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BriaCell Therapeutics Corp

BriaCell Therapeutics Corp (BCT)

10,60
0,00
( 0,00% )
Aktualisiert: 01:00:00

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
10,60
Gebot
10,50
Fragen
11,05
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
10,60
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
18.284.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-40,44
Gewinn pro Aktie (EPS)
-0,26
Erlöse
-
Nettogewinn
-4,79M

Über BriaCell Therapeutics Corp

Sektor
Aircraft
Branche
Business Services, Nec
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2009
BriaCell Therapeutics Corp is listed in the Aircraft sector of the TSX Venture Börse with ticker BCT. The last closing price for BriaCell Therapeutics was $10,60. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 0,00 to $ 0,00.

BriaCell Therapeutics currently has 18.284.000 shares in issue. The market capitalisation of BriaCell Therapeutics is $193,81 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -40.44.

BCT Neueste Nachrichten

BriaCell Announces Proposed Effective Date of Share Consolidation

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update

BriaCell selected to present at the American Association for Cancer Research (AACR) Annual Meeting 2022Corporate buyback program continues; 1,031,672 shares and 200,740 warrants repurchased since...

BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders

NEW YORK and VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), is pleased to announce...

BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 29, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Announces Insiders’ Intention to Purchase up to 10% of Public Market Securities

Insiders intend to acquire up to approximately 10% of BriaCell’s basic common shares, or 1.59 million sharesCorporate buyback program will continue; 501,703 shares and 143,236 warrants repurchased...

BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®

NEW YORK and VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

BCT - Frequently Asked Questions (FAQ)

What is the current BriaCell Therapeutics share price?
The current share price of BriaCell Therapeutics is $ 10,60
How many BriaCell Therapeutics shares are in issue?
BriaCell Therapeutics has 18.284.000 shares in issue
What is the market cap of BriaCell Therapeutics?
The market capitalisation of BriaCell Therapeutics is CAD 193,81M
What is the 1 year trading range for BriaCell Therapeutics share price?
BriaCell Therapeutics has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of BriaCell Therapeutics?
The price to earnings ratio of BriaCell Therapeutics is -40,44
What is the reporting currency for BriaCell Therapeutics?
BriaCell Therapeutics reports financial results in USD
What is the latest annual profit for BriaCell Therapeutics?
The latest annual profit of BriaCell Therapeutics is USD -4,79M
What is the registered address of BriaCell Therapeutics?
The registered address for BriaCell Therapeutics is SUITE 300 - 235 WEST 15TH STREET, VANCOUVER, BRITISH COLUMBIA, V7T 2X1
What is the BriaCell Therapeutics website address?
The website address for BriaCell Therapeutics is www.briacell.com
Which industry sector does BriaCell Therapeutics operate in?
BriaCell Therapeutics operates in the BUSINESS SERVICES, NEC sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CVY.PCavalry Capital Corp
$ 0,07
(100,00%)
3k
HMANHuntsman Exploration Inc
$ 0,05
(66,67%)
40k
RTHRathdowney Resources Ltd
$ 0,025
(66,67%)
5,04k
ALMAlliance Mining Corp
$ 0,14
(64,71%)
40k
GXY.PGalaxy Ventures Inc
$ 0,115
(53,33%)
1.000
AGETAGEDB Technology Ltd
$ 0,025
(-86,11%)
19,5k
CANSWildpack Beverage Inc
$ 0,005
(-50,00%)
2k
IDI.HIndico Resources Ltd
$ 0,35
(-50,00%)
1,5k
CLMConsolidated Lithium Metals Inc
$ 0,005
(-50,00%)
6k
ZBNIZeb Nickel Corp
$ 0,05
(-47,37%)
1,25k
DRYDryden Gold Corp
$ 0,135
(-3,57%)
2,84M
LUCALuca Mining Corp
$ 0,93
(2,20%)
2,82M
OMIOrosur Mining Inc
$ 0,17
(-10,53%)
2,76M
RSLVReyna Silver Corp
$ 0,07
(0,00%)
2,65M
RIORio2 Limited New
$ 0,80
(12,68%)
2,61M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock